BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
CDSCO Releases Draft Guidance on Pharmacovigilance for Vaccines June 4, 2024 The Central Drugs Standard Control Organisation (CDSCO) has published a draft guidance document on pharmacovigilance requirements for human vaccines, inviting feedback from stakeholders.
iMeUsWe Partners with MapMyGenome to Launch DNA Testing Services June 3, 2024 Pune-based iMeUsWe, an Indian genealogy platform, has launched DNA testing services in collaboration with Hyderabad-based MapMyGenome, a genetic testing service provider.
Tata Capital Healthcare Fund II Invests $20 Mn in Orbicular Pharmaceutical Technologies June 3, 2024 Tata Capital Healthcare Fund II (TCHF II), a healthcare-focused private equity fund, has invested approximately $20 million in Orbicular Pharmaceutical Technologies, a Hyderabad-based company that develops complex generics for global markets.
BLR-based G-KnowMe Teams Up with Cambridge for Cancer Genome Interpretation May 28, 2024 Bengaluru-based informatics startup G-KnowMe has partnered with researchers at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust (CUH) in the UK to automate the clinical interpretation of whole genome sequencing (WGS) data for cancer treatment.
DoP Launches New Portal to Implement R&D Policy in Pharma-Medtech Sector May 27, 2024 The ICPMR is set to lead the Drug Discovery Mission, a multi-institutional initiative that pools the strengths of various research institutions.
Torrent Pharma Board Approves INR 5,000 Cr Fundraising Plan May 27, 2024 However, the final approval is pending and is anticipated to be addressed at the upcoming annual general meeting (AGM).
After Mankind Pharma, Now Blackstone, KKR & Carlyle in Talks to Acquire Bharat Serums & Vaccines May 23, 2024 Advent International, the current owner of BSV, aims to sell its entire stake. Non-binding bids are expected by the end of this month.
Serum Institute Acquires 20% Stake in Needle-Free Injection Tech Firm IntegriMedical May 20, 2024 Serum Institute of India (SII), a leading vaccine manufacturer, has acquired a 20% stake in medical device company IntegriMedical. This investment aims to advance needle-free injection technology.
APTI Calls for Common Pharmacist Registration Across India May 17, 2024 The proposed common registration process would encompass these professionals, providing empirical data on all registered pharmacists.
Annapurna Das Taking Over Takeda’s GM Position in India May 17, 2024 Takeda Biopharmaceuticals, a Japan-headquartered pharmaceutical firm, has named Annapurna Das the general manager for its India operations to bolster its standing in the country's healthcare sector.
Cipla to Invest Additional INR 26 Cr in Achira Labs May 17, 2024 Upon the completion of the first tranche of the new investment, Cipla’s stake in Achira Labs will increase to 27.27% of the total voting rights.
Cipla Promoters to Offload 2.5% Stake at INR 2,650 Cr May 16, 2024 Promoters Yusuf Khwaja Hamied and Mustafa Khwaja Hamied plan to sell the stake to institutional investors, potentially generating up to INR 1,849 Cr
